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Abstract
Despite a wide base of research suggesting a major role for dysfunctional metacog-
nitions in contributing to anxiety, their role in explaining psychological distress in 
the context of the COVID-19 pandemic remains unclear. In this study we investi-
gated whether metacognitions would predict anxiety, while controlling for fear and 
perceived danger of COVID-19. A total of 862 individuals were included in this 
study. Participants completed sociodemographic questions, emotional state ques-
tions relating to COVID-19, the Metacognitions Questionnaire‐30, and the General-
ized Anxiety Disorder-7. Results showed that both negative beliefs about thoughts 
concerning uncontrollability and danger, and cognitive self-consciousness were sig-
nificant predictors of anxiety beyond the fear and perceived danger of COVID-19. 
Future studies involving clinical populations are needed to investigate the longer-
term impact of metacognitions in the maintenance and exacerbation of anxiety asso-
ciated with the fear and perceived danger of COVID-19.
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Introduction
A new coronavirus called SARS-CoV-2 by the Coronavirus Working Group (CSG) 
(Gorbalenya et  al., 2020) was reported in China in December 2019 (Zhu et  al., 
2020). On February 11, 2020, the disease caused by the new coronavirus was offi-
cially named COVID-19 by the World Health Organization (WHO). Evidence 
has shown that COVID-19 is a different clone from beta-corona viruses associ-
ated with the human Severe Acute Respiratory Syndrome (SARS) and the Middle 
East Respiratory Syndrome (MERS) (Zhu et  al., 2020). COVID-19 has become 
a global emergency state of health in just a few weeks with its unique transmis-
sion rate (Wang et al., 2020a). In addition, the number of confirmed and suspected 
cases has increased rapidly not only in China but also in other countries around the 
world (Munster et al., 2020). According to reports from the WHO, there were more 
than 219 million confirmed cases to October 16, 2021 around the globe, of which 
more than 4.5 million resulted in death. The outbreak has so far been reported in 
218 countries and territories outside of China. Previous studies emphasized that 
psychological disturbance, namely post-traumatic stress disorder, generalized anxi-
ety disorder and depressive disorder may increase in society during and after the 
major outbreaks (e.g. SARS, MERS) (Mak et al., 2009; Paek et al., 2016). Recent 
evidence has shown this to be the case with the detrimental psychological effects of 
the COVID-19 outbreak found to include anxiety, depression (Nikčević & Spada, 
2020) somatization, psychological distress (Salazar de Pablo et al., 2020), sleep dis-
turbances (Xiao et al., 2020), suicidal thoughts (Mamun et al., 2020), and post-trau-
matic stress symptoms (Bo et al., 2020).
In addition, several studies have emphasized the emergence of fear specific to 
COVID-19 (Ahorsu et al., 2020; Asmundson & Taylor, 2020). Despite fear can be 
acknowledged as a habitual response to crisis situations, occasionally this response 
may escalate into excessive anxiety and worry during global life-threatening situ-
ations (Haig-Ferguson et  al., 2020). Mertens (2020) identified several factors that 
may elevate the fear of COVID-19 including perceived risks to loved ones, health 
anxiety, and social media use. Recent studies have also shown that the perceived 
danger of COVID-19 may escalate stress (Sica et al., 2021; Wang et al., 2020b) and 
will vary according to contextual differences, including age, gender, and community 
size (Kimhi et al., 2020). The impact of psychological distress on perceived danger 
towards adversity among may be particularly marked in youth populations (Braun-
Lewensohn & Al-Sayed, 2018; Kimhi et al., 2017).
The effects of fear and perceived danger of COVID-19 on numerous domains on 
psychological distress appear to be wider than expected with faster transmission of 
information across the globe (Goyal et al., 2020; Lee et al., 2020; Sica et al., 2021; 
Wang et al., 2020b; Yıldırım et al., 2020). These studies clearly point to the fact that 
the fear and perceived danger of COVID-19 are co-occurring with anxiety, but the 
mechanisms linking these constructs remain unclear.
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The Metacognitive Model of Psychopathology and Its Relevance in Understanding 
Psychological Distress During the COVID‑19 Pandemic
According to the metacognitive model of psychopathology proposed by Wells and 
Matthews (1996) psychological distress can be escalated by the presence of meta-
cognitions. Metacognitions refer to beliefs we hold about the meaning of internal 
experiences and how these experiences should be controlled. Positive metacogni-
tions (“If I worry, I will be prepared”) are linked to the initiation of maladaptive 
coping strategies (such as worry, rumination and thought suppression). Negative 
metacognitions reflect judgements about the uncontrollability and danger of coping 
strategies and the consequences of adopting such strategies (e.g. loss of control over 
thinking, lack of cognitive confidence) (Corcoran & Segal, 2008). Consequently, 
the presence of metacognitions (and associated maladaptive coping strategies) can 
lead to an aggravation of distress (Wells, 2008). Previous studies have shown the 
role of metacognitions in numerous mental health disorders such as anxiety disor-
ders, major depression, schizophrenia, and addictive behaviours (Aydin et al., 2016; 
Aydın et al., 2019; Papageorgiou & Wells, 2001; Spada et al., 2015). In a similar 
vein, researchers have demonstrated that metacognitions are associated with an 
increase in perceived stress as well as the negative affect (Spada et al., 2008b). Addi-
tionally, metacognitions may cause and maintain stress through the perseveration of 
worry (Cook et al., 2015) and may adversely affect the perception of illness (Pure-
wal & Fisher, 2018).
Research has suggested that COVID-19 guidelines (e.g., handwashing) and 
excessive media exposure may have worsened OCD-type symptoms among adoles-
cents and children (Tanir et al., 2020). Repetitive thoughts on this infectious disease 
have been found to elevate anxiety and risk of developing trauma (Skalski et  al., 
2020). However, these studies only measured anxiety levels as a ‘manifestation’ of 
the impact of COVID-19 pandemic. It still remains unclear which type of beliefs 
and thinking patterns may play a role in these changes in psychological distress. It 
is well-known that dysfunctional metacognitions and associated patterns of cop-
ing may play a significant role in a wide range of psychopathological presentations 
(Cartwright-Hatton et al., 2004; Laghi et al., 2018; Mazloom et al., 2016; Moneta, 
2011) with recent research supporting the notion that metacognitions may shape 
one’s negative emotions and psychological distress symptoms (Capobianco et  al., 
2019).
Previous research has demonstrated the potential relationship between metacog-
nitions and health anxiety symptoms (Melli et al., 2016, 2018), additionally, meta-
cognitions have been found to be a potential mediator of behaviours relating to the 
fear of COVID-19 (Hashemi et  al., 2020). Moreover, it was reported that higher 
perceived dangerousness and/or susceptibility (i.e. perceived probability of perish-
ing from and/or contracting COVID-19) is associated with higher stress and anxi-
ety levels (Sica et al., 2021; Wang et al., 2020a). Therefore, we postulate that there 
may be a potential relationship between fear and perceived danger of COVID-19, 
metacognitions, and anxiety. However, these links have not been explored during 
the COVID-19 outbreak. In this study we attempt to discern the possible contribu-
tion of metacognitions to anxiety, while controlling for fear and perceived danger of 
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COVID-19. We hypothesized that metacognitions would be associated to anxiety 
whilst controlling for fear and perceived danger of COVID-19. We believe that the 
possible identification of metacognitions as an independent predictor of anxiety may 
help focus on essential psychotherapeutic interventions to alleviate anxiety levels 
during the COVID-19 pandemic.
Method
Participants
A virtual snowball (chain) sampling method was used for the study. We placed an 
advertisement on the Internet and made an announcement through social media 
platforms for participant recruitment in Turkey and Turkish Republic of Northern 
Cyprus (TRNC). The participants’ responses were thus collected through online 
questionnaires. The participants did not receive any incentive or allowance. The 
single inclusion criterion was to be at least 18 years of age. The single exclusion 
criterion was to be currently diagnosed and suffering from any form of psychiatric 
disorder. A total of 1011 individuals participated in the study with 82 participants 
failing to complete one or more questionnaires. Therefore, statistical analyses were 
performed with 929 participants. All participants provided consent to participate in 
the study. The study was approved by the Department of Psychology, International 
University of Sarajevo (reference no: KISBU/EK/2020/003).
Measures
Metacognitions Questionnaire 30 (MCQ‑30; Wells & Cartwright‑Hatton, 2004; Tosun 
& Irak, 2008)
The MCQ-30 is a self-report measure to assess metacognitions. The MCQ-30 con-
sists of 30 items split into five factors: (i) positive beliefs about worry (e.g., “Wor-
rying helps me to get things sorted out in my mind”); (ii) negative beliefs about 
thoughts concerning danger and uncontrollability (e.g., “My worrying could make 
me go mad”); (iii) beliefs about the need to control thoughts (e.g., “I should be in 
control of my thoughts all of the time”); (iv) cognitive confidence (e.g., “I have lit-
tle confidence in my memory for words and names”); and (v) cognitive self-con-
sciousness (e.g., “I am constantly aware of my thinking”). The MCQ-30 is scored 
on a 4-point Likert scale (“Do not agree” to “Agree very much”). The total score 
ranges from 30 to 120, with higher scores reflecting higher levels of maladaptive 
metacognitions. The MCQ-30 has demonstrated good internal consistency and con-
vergent validity and has acceptable test–retest reliability (Spada et al., 2008a; Wells 
& Cartwright-Hatton, 2004). The Turkish version of MCQ-30 was used in present 
study (Cronbach’s α = 0.86) (Tosun & Irak, 2008). Cronbach’s α was found to be 
0.91 in our study.
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Generalized Anxiety Disorder‑7 (GAD‑7; Spitzer et al., 2006; Konkan et al., 2013)
The GAD-7 is a self-report measure to assess anxiety. The GAD-7 consists of seven 
items assessing anxiety symptoms in the past two weeks. The GAD-7 is scored 
on 4-point Likert scale scored from zero to three (0 = not at all, 1 = several days, 
2 = more than half the days, 3 = nearly every day). Three levels of anxiety are identi-
fied: (i) 5–9 as mild; (ii) 10–14 as moderate; and (iii) 15+ severe. The total score 
ranges from 0 to 21, with higher scores reflecting higher levels of anxiety. The Turk-
ish version of GAD-7 was used in present study (Cronbach’s α = 0.85) (Konkan 
et al., 2013). Cronbach’s α was found to be 0.90 in our study.
Sociodemographic and Emotional State Questions Relating to COVID‑19
A form including questions about participants’ age, gender, academic qualifications, 
and marital status was developed by researchers. The form also presented questions 
regarding levels of fear and perceived danger of COVID-19 (i.e., “What is your fear 
of the COVID-19 disease?” and “How do you rate the danger of the COVID-19 dis-
ease?”). Participants were required to rate their responses from 0 to 7. Higher scores 
indicated higher levels of fear and perceived danger of COVID-19.
Statistical Analysis
Normality was checked through skewness, kurtosis, and Shapiro–Wilk testing. All 
variables were found to be normally distributed across the sample. Sociodemo-
graphic data and the descriptive statistics for the responses provided to the emo-
tional state questions relating to COVID-19, the MCQ-30 and the GAD-7 are pre-
sented in Tables 1 and 2, respectively.
Table 1  Sociodemographic 
characteristics of the 
participants
n % M SD









Primary education (8 years of 
schooling)
15 1.6
High school 84 9.0
Bachelor degree or above 828 89.1
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To explore the relationship between emotional state questions relating to COVID-
19, the MCQ-30 factors and GAD-7, Pearson’s Product-Moment correlational anal-
yses were performed. Along with significant variables detected in the correlational 
analyses, hierarchical multiple regression was run to inspect the value of MCQ-30 
factors in predicting GAD-7 scores while controlling for emotional state questions 
relating to COVID-19. Age and gender were inserted in the first step to control 
their effects on GAD-7. Fear of COVID-19, perceived danger of COVID-19, and 
MCQ-30 factors were entered into the following steps, respectively. Cohen’s f2 that 
is seen convenient for calculating the effect size was computed; Cohen’s guidelines: 
f2 ≥ 0.02, f2 ≥ 0.15, and f2 ≥ 0.35 representing small, medium, and large effect sizes, 
respectively (Cohen, 1988). The statistical significance (p) value was set to 0.05 
and all analyses were estimated with the statistical analysis software (IBM Corp., 
Armonk, NY. SPSS Statistics 22.0.).
Table 2  Mean values of MCQ-30 factors, GAD-7, and the participants’ responses to questions relating to 
fear and perceived danger of COVID-19
n % M SD
MCQ-30-Positive Beliefs about Worry 929 11.8 4.32
MCQ-30-Negative Beliefs about Thoughts Concerning 
Uncontrollability and Danger
929 13.6 4.56
MCQ-30-Beliefs about the Need to Control Thoughts 929 11.8 4.07
MCQ-30-Cognitive Confidence 929 13.3 4.54
MCQ-30-Cognitive Self-consciousness 929 16.1 4.08
GAD-7 929 5.17 4.84
What is your fear of the COVID-19 disease?
None 90 9.7
Minor 92 9.9
Very low 113 12.2
Low 175 18.8
High 158 17.0
Very high 92 9.9
Extremely high 209 22.5
How do you rate the danger of the COVID-19 disease?
Non-existent 11 1.2
Minor 31 3.3
Very low 91 9.8
Low 149 16.0
High 207 22.3
Very high 132 14.2
Extremely high 308 33.2
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Results
Sample Characteristics
According to the descriptive statistics, most of our participants were comprised 
by females. Almost half of the sample was single, and the vast majority had a 
bachelor’s degree (Table  1). Almost a third of the sample (33.2%) considered 
COVID-19 to be dangerous with 209 participants reporting they were afraid of 
the disease. Mean values of the utilized tests are demonstrated in Table 2.
Correlation Analyses
The correlational analyses revealed that GAD-7 was positively correlated with 
the fear of COVID-19, the perceived danger of COVID-19, and all factors of the 
MCQ-30. Age and gender were negatively correlated with GAD-7. The fear of 
COVID-19 was positively correlated with all the factors of the MCQ-30 with the 
exception of cognitive self-consciousness. Perceived danger of COVID-19 was 
positively correlated with negative beliefs about thoughts concerning uncontrol-
lability and danger and cognitive confidence. All correlation data is presented in 
Table 3.
Hierarchical Multiple Regression Analysis
The results of the hierarchical multiple regression analysis are shown in Table 4. In 
the first step, age and gender were significant predictors (F(2, 925) = 11.89, p < 0.01) 
of GAD-7 scores, and accounted for 3% of the variance. In the second step, the 
fear of COVID-19 contributed significantly to GAD-7 scores, and accounted for 
an increase to 10% of the variance explained (F(3, 924) = 46.25, p < 0.01). In the 
third step, perceived danger of COVID-19 was not a significant predictor of GAD-7, 
consequently the explained variance remained unchanged. In the fourth step, nega-
tive beliefs about thoughts concerning uncontrollability and danger, and cognitive 
self-consciousness were significant predictors of GAD-7 scores, accounting for an 
increase to 20% of the variance explained (F(9, 918) = 50.52, p < 0.01). The overall 
model effect size was large (f2 ≥ 0.35).
Discussion
The aim of the present study was to investigate to what extent metacognitions 
may contribute to anxiety when fear and perceived danger of COVID-19 are con-
trolled for. Despite the detrimental effects of the perceptions towards the COVID-
19 outbreak, the result of the multiple regression analysis showed that both nega-
tive beliefs about thoughts concerning uncontrollability and danger, and cognitive 
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self-consciousness were significant predictors of anxiety above and beyond the fear 
and perceived danger of COVID-19.
How can we explain these findings within a metacognitive paradigm? Negative 
beliefs about thoughts concerning uncontrollability and danger are a marker of the 
activation of repetitive negative thinking patterns (e.g., worry) as a means of coping. 
These beliefs have been found to be strong predictors of generalized anxiety disor-
der (Wells, 1995; Wells & Carter, 2001). Previous research has also highlighted the 
impact of COVID-19 based on perceived risk, anxiety and depression levels (Choi 
et al., 2020; Hyland et al., 2020; Khademian et al., 2021; Moghanibashi-Mansou-
rieh, 2020) which are closely linked to worry and other forms of maladaptive cop-
ing. Beliefs about thoughts concerning uncontrollability and danger may bring to 
increased levels of hypersensitiveness to fear and perceived danger of COVID-19, 
leading to the development of corresponding behavioral routines like self-constraints 
Table 4  Hierarchical regression analysis with the fear and perceived danger of COVID-19 and MCQ-30 
factors as predictors of GAD-7
n = 929; MCQ-30-PBW: Metacognitions Questionnaire 30-Positive Beliefs about Worry; MCQ-30-NBT: 
Metacognitions Questionnaire 30-Negative Beliefs about Thoughts Concerning Uncontrollability and 
Danger; MCQ-30-NCT: Metacognitions Questionnaire 30-Beliefs about the Need to Control Thoughts; 
MCQ-30-CC: Metacognitions Questionnaire 30-Cognitive Confidence; MCQ-30-CSC: Metacognitions 
Questionnaire 30-Cognitive Self-consciousness. Significant observations are highlighted in bold
Predictor B SE Beta (b) t p R2
Step 1 0.03
Age  − 0.01 0.00  − 0.13  − 4.12 0.00
Gender  − 0.17 0.07  − 0.08  − 2.54 0.01
Step 2 0.13
Age  − 0.01 0.00  − 0.15  − 5.00 0.00
Gender  − 0.09 0.06  − 0.04  − 1.38 0.17
Fear of COVID-19 0.14 0.01 0.33 10.59 0.00
Step 3 0.13
Age  − 0.01 0.00  − 0.16  − 5.03 0.00
Gender  − 0.09 0.06  − 0.04  − 1.36 0.18
Fear of COVID-19 0.13 0.02 0.30 7.57 0.00
Perceived Danger of COVID-19 0.03 0.02 0.05 1.37 0.17
Step 4 0.33
Age  − 0.01 0.00  − 0.10  − 3.62 0.00
Gender 0.01 0.06 0.01 0.26 0.79
Fear of COVID-19 0.09 0.02 0.21 6.11 0.00
Perceived Danger of COVID-19 0.02 0.02 0.04 1.21 0.23
MCQ-30-PBW 0.00 0.01  − 0.02  − 0.65 0.51
MCQ-30-NBT 0.10 0.01 0.54 13.94 0.00
MCQ-30-NCT 0.00 0.01 0.00 0.05 0.96
MCQ-30-CC 0.00 0.01  − 0.02  − 0.72 0.47
MCQ-30-CSC  − 0.03 0.01  − 0.12  − 3.29 0.00
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towards any form of exposure to media coverage or news relating to COVID-19, 
avoidance of social engagement, threat monitoring, etc. which may escalate anxi-
ety and further confirm a sense of uncontrollability and danger (Nikčević & Spada, 
2020; Nikčević et al., 2021).
Turning now to the findings on cognitive self-consciousness, the second meta-
cognition found to independently predict higher anxiety levels, it is plausible to 
assume that individuals who report paying close attention to their thoughts/engaging 
in excessive self-monitoring will observe/notice more fear and perceived danger of 
COVID-19. In line with this view, Hatabu et al. (2020) argued that individuals with 
higher scores in private self-consciousness tend to take strict protection measures 
to address the COVID-19 guidelines. A possible reason underlying this behavior 
attitude may be explained by excessive cognitive monitoring which triggers indi-
viduals to obey the guidelines to get relief from anxiety. In other words, individu-
als may attempt to regulate fear and perceived danger of COVID-19 by cognitive 
reframing (e.g., “I should be careful about COVID-19”) which may then evolve into 
heightened cognitive self-consciousness (e.g., “I think a lot about, and notice, my 
thoughts and fears about COVID-19”) which may, in turn, be accompanied by nega-
tive beliefs about thoughts concerning uncontrollability and danger (e.g., “I cannot 
ignore my worrying thoughts about COVID-19”), thus elevating anxiety levels.
In a recent study conducted by Li et al. (2020) it was suggested that Cognitive 
Behaviour Therapy (CBT) may be a useful intervention to tackle a wide range of 
psychopathology during COVID-19. However, typically, the cognitive interven-
tions within CBT only involve challenging thoughts with factual information which 
may have been the reason behind smaller effects on anxiety symptoms. Wang et al. 
(2021) have demonstrated that anxiety interventions involving cognitive emotion 
regulation strategies (rather than the modification of the content of thinking) may 
be more effective. Furthermore Xu et  al. (2020) have also highlighted the impor-
tance of wider cognitive interventions that involve one’s perception of stress where 
individuals may not be worried about worrying and see it as a resource to address 
the guidelines during COVID-19. The principal psychological therapy that focus on 
the modification of metacognitions and associated control strategies (worry, rumi-
nation and thought suppression) is Metacognitive Therapy (Wells, 2013). A wide 
evidence base has shown that metacognitive interventions such as detached mindful-
ness, attention training and the restructuring of metacognitions may bring to signifi-
cant improvements in psychological distress (Normann et al., 2014). It is plausible 
to assume that this form of psychological therapy may benefit individuals who are 
trapped in self-referent forms of coping (worry, rumination, etc.) about fears and 
perceived danger of COVID-19.
It should also be noted, that both Turkish and TRNC governments have been 
applying several significant precautions including prohibition of crowded gather-
ings, closing public facilities, restricting public transportation, requiring self-isola-
tion, closing country borders, suspension of flights to/from risky countries to limit 
the spread of the COVID-19 outbreak. However, each of these interventions may 
also affect the psychological well-being of the society and there is still gap in stud-
ies focusing on effective targets to alleviate the psychological disturbances during 
COVID-19 pandemic. Understanding the role of metacognitions and associated 
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forms of coping in the escalation of COVID-19 psychological distress (fear and dan-
ger perception) may be of value going forward.
There are several limitations to our study that need to be noted. The participants’ 
mental status was not assessed with a structured clinical interview. Therefore, our 
sample may not thoroughly reflect the non-psychiatric population. The cross-sec-
tional design of the study precludes us to draw strong conclusions regarding causa-
tive associations between the study variables. The potential for selection bias should 
also be considered with web-based survey methodology. Lastly, we have measured 
the intensity of the emotions and perceptions related to COVID-19 with subjective 
gradings, hence this may limit our interpretations.
In conclusion, this study investigated the impact of metacognitions on anxiety 
during the COVID-19 outbreak and attempted to outline how anxiety may be mag-
nified by the presence of metacognitions beyond the fear and perceived danger of 
COVID-19. In March 2020, WHO declared a wide range of recommendations to 
overcome mental health issues and they emphasized the potential detrimental effects 
of the COVID-19 outbreak on psychological well-being (World Health Organiza-
tion, 2020). Primary issues to be addressed in further studies may involve the impact 
of interventions that consider a wider focus on cognition including metacognitions.
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